Prime Medicine

PRME - Prime Medicine • Financials

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
0
-200
-
0%
L
133
L
-122
-
-179
-9
1
-188
0
0
-
-
12/2024
3
-196
-
L
L
153
L
-190
-
-149
-7
196
-156
0
0
-
-
12/2025
5
-201
-
L
L
121
L
-178
-
-192
-5
152
-196
0
0
-
-